Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Irritable Bowel Syndrome, April 2023 Free Subscription Abstracts Retrieve all available abstracts of the following 78 articles: HTML format

Single Articles

1. SCHMIDT M, Raczyk M
   FODMAP reduction strategies for nutritionally valuable baking products: current state and future challenges.
   Crit Rev Food Sci Nutr. 2023 Mar 31:1-18. doi: 10.1080/10408398.2023.2195026.
   PubMed    
   Abstract available
   
   

2. 
   Correction to: Post-infectious irritable bowel syndrome following a diagnosis of traveller's diarrhoea: a comprehensive characterization of clinical and laboratory parameters.
   J Travel Med. 2023 Mar 29:taad040. doi: 10.1093.
   PubMed    
   
   
   

3. DONG LW, Chen YY, Chen CC, Ma ZC, et al
   Adenosine 2A receptor contributes to the facilitation of post-infectious irritable bowel syndrome by gammadelta T cells via the PKA/CREB/NF-kappaB signaling pathway.
   World J Gastroenterol. 2023;29:1475-1491.
   PubMed    
   Abstract available
   
   

4. BLACK CJ, McKenzie YA, Scofield-Marlowe M, Setter P, et al
   Top 10 research priorities for irritable bowel syndrome: results of a James Lind Alliance priority setting partnership.
   Lancet Gastroenterol Hepatol. 2023 Mar 24:S2468-1253(23)00072.
   PubMed    
   
   
   

5. SCARPELLINI E, Broeders B, Schol J, Santori P, et al
   The Use of Peppermint Oil in Gastroenterology.
   Curr Pharm Des. 2023 Mar 30. doi: 10.2174/1381612829666230328163449.
   PubMed    
   Abstract available
   
   

6. RAJAMANIKAM A, Isa MNM, Samudi C, Devaraj S, et al
   Gut bacteria influence Blastocystis sp. phenotypes and may trigger pathogenicity.
   PLoS Negl Trop Dis. 2023;17:e0011170.
   PubMed    
   Abstract available
   
   

7. MULAK A, Freud T, Waluga M, Bangdiwala SI, et al
   Sex- and gender-related differences in the prevalence and burden of disorders of gut-brain interaction in Poland.
   Neurogastroenterol Motil. 2023 Mar 29:e14568. doi: 10.1111/nmo.14568.
   PubMed    
   Abstract available
   
   

8. EVANS KM, Averill MM, Harris CL
   Disordered eating and eating competence in members of online irritable bowel syndrome support groups.
   Neurogastroenterol Motil. 2023 Mar 29:e14584. doi: 10.1111/nmo.14584.
   PubMed    
   Abstract available
   
   

9. DERVIN H, Zarate-Lopez N, Sweis R, Mensah A, et al
   Low prevalence of positive hydrogen breath tests in patients with functional gastrointestinal conditions and hypermobile Ehlers-Danlos syndrome.
   Neurogastroenterol Motil. 2023 Mar 29:e14570. doi: 10.1111/nmo.14570.
   PubMed    
   Abstract available
   
   

10. RODRIGUES DM, Poitras P, Day AG, Sperber AD, et al
    The epidemiology and impact of disorders of gut-brain interaction in Canada: Results from the Rome Foundation Global Epidemiologic Study.
    Neurogastroenterol Motil. 2023 Mar 29:e14585. doi: 10.1111/nmo.14585.
    PubMed    
    Abstract available
    
    

11. MUJAGIC Z, Brouns J, Keszthelyi D, Muris JW, et al
    [Dietary interventions in irritable bowel syndrome: 10 tips].
    Ned Tijdschr Geneeskd. 2023;167:D7356.
    PubMed    
    Abstract available
    
    

12. PARK YS, Kang SB, Marchelletta RR, Penrose HM, et al
    The ClC-2 Chloride Channel Activator, Lubiprostone, Improves Intestinal Barrier Function in Biopsies from Crohn's Disease but Not Ulcerative Colitis Patients.
    Pharmaceutics. 2023;15:811.
    PubMed    
    Abstract available
    
    

13. RIEZZO G, Prospero L, Orlando A, Linsalata M, et al
    A Tritordeum-Based Diet for Female Patients with Diarrhea-Predominant Irritable Bowel Syndrome: Effects on Abdominal Bloating and Psychological Symptoms.
    Nutrients. 2023;15:1361.
    PubMed    
    Abstract available
    
    

14. BANASZAK M, Gorna I, Wozniak D, Przyslawski J, et al
    Association between Gut Dysbiosis and the Occurrence of SIBO, LIBO, SIFO and IMO.
    Microorganisms. 2023;11:573.
    PubMed    
    Abstract available
    
    

15. DAHIYA D, Nigam PS
    Biotherapy Using Probiotics as Therapeutic Agents to Restore the Gut Microbiota to Relieve Gastrointestinal Tract Inflammation, IBD, IBS and Prevent Induction of Cancer.
    Int J Mol Sci. 2023;24:5748.
    PubMed    
    Abstract available
    
    

16. OMAROVA S, Awad K, Moos V, Puning C, et al
    Intestinal Barrier in Post-Campylobacter jejuni Irritable Bowel Syndrome.
    Biomolecules. 2023;13:449.
    PubMed    
    Abstract available
    
    

17. REJ A, Penny HA
    Current evidence for dietary therapies in irritable bowel syndrome.
    Curr Opin Gastroenterol. 2023 Mar 2. doi: 10.1097/MOG.0000000000000930.
    PubMed    
    Abstract available
    
    

18. CAMACHO S, Diaz A, Perez P, Batalla H, et al
    Sexual dysfunction worsens both the general and specific quality of life of women with irritable bowel syndrome. A cross-sectional study.
    BMC Womens Health. 2023;23:134.
    PubMed    
    Abstract available
    
    

19. ERMOLENKO E, Sitkin S, Vakhitov T, Solovyeva O, et al
    Evaluation of the effectiveness of personalised therapy for the patients with irritable bowel syndrome.
    Benef Microbes. 2023 Mar 27:1-12. doi: 10.3920/BM2022.0053.
    PubMed    
    Abstract available
    
    

20. ATMANI K, Meleine M, Langlois L, Coeffier M, et al
    Involvement of acid sensing ion channel (ASIC)-3 in an acute urinary bladder-colon cross sensitization model in rodent.
    Front Pain Res (Lausanne). 2023;4:1083514.
    PubMed    
    Abstract available
    
    

21. SUN Z, Wang X, Feng S, Xie C, et al
    A review of neuroendocrine immune system abnormalities in IBS based on the brain-gut axis and research progress of acupuncture intervention.
    Front Neurosci. 2023;17:934341.
    PubMed    
    Abstract available
    
    

22. TANNOUS S, Stellbrinck T, Hoter A, Naim HY, et al
    Interaction between the alpha-glucosidases, sucrase-isomaltase and maltase-glucoamylase, in human intestinal brush border membranes and its potential impact on disaccharide digestion.
    Front Mol Biosci. 2023;10:1160860.
    PubMed    
    Abstract available
    
    

23. PHILIPS CA, Theruvath AH, Raveendran R, Ahamed R, et al
    Clinical outcomes associated with complementary and alternative medicine-related "immunity-boosting" practices in patients with cirrhosis during the COVID-19 pandemic - an observational study.
    Medicine (Baltimore). 2023;102:e33365.
    PubMed    
    Abstract available
    
    

24. STAUDACHER HM, Gibson PR
    Traditional Dietary Advice, Low FODMAP Diet, or Gluten-Free Diet for IBS: Growing Understanding but Uncertainties Remain.
    Clin Gastroenterol Hepatol. 2023;21:1119-1120.
    PubMed    
    
    
    

25. KHAYAT A, Aldharman SS, Alharbi NN, Alayyaf AS, et al
    Regional and seasonal variations in functional abdominal pain and functional constipation prevalence among Saudi children.
    SAGE Open Med. 2023;11:20503121231163519.
    PubMed    
    Abstract available
    
    

26. MATHKHOR AJ, Ibraheem NM
    Prevalence and Impact of obesity on fibromyalgia syndrome and its allied symptoms.
    J Family Med Prim Care. 2023;12:123-127.
    PubMed    
    Abstract available
    
    

27. YAMAMOTO R, Yamamoto A, Masaoka T, Homma K, et al
    Early symptoms preceding post-infectious irritable bowel syndrome following COVID-19: a retrospective observational study incorporating daily gastrointestinal symptoms.
    BMC Gastroenterol. 2023;23:108.
    PubMed    
    Abstract available
    
    

28. TAKEOKA A, Kimura T, Hara S, Hamaguchi T, et al
    Prevalence of Irritable Bowel Syndrome in Japan, China, and South Korea: An International Cross-sectional Study.
    J Neurogastroenterol Motil. 2023;29:229-237.
    PubMed    
    Abstract available
    
    

29. SEMEN M, Lychkovska O, Kaminskyy D, Yavorskyi O, et al
    Heart Rate Variability and Somatization in Adolescents With Irritable Bowel Syndrome.
    J Neurogastroenterol Motil. 2023;29:208-217.
    PubMed    
    Abstract available
    
    

30. SHIN CM
    Prevalence of Irritable Bowel Syndrome in East Asia: Are There Differences Between Countries?
    J Neurogastroenterol Motil. 2023;29:127-128.
    PubMed    
    
    
    

31. JAAFARI H, Houghton LA, West RM, Agrawal A, et al
    The national prevalence of disorders of gut brain interaction in the United Kingdom in comparison to their worldwide prevalence: Results from the Rome foundation global epidemiology study.
    Neurogastroenterol Motil. 2023 Apr 5:e14574. doi: 10.1111/nmo.14574.
    PubMed    
    Abstract available
    
    

32. HENICK D, Italiano T, Person H, Keefer L, et al
    Medical students' knowledge and perception of irritable bowel syndrome in comparison to inflammatory bowel disease.
    Neurogastroenterol Motil. 2023 Apr 5:e14576. doi: 10.1111/nmo.14576.
    PubMed    
    Abstract available
    
    

33. BROEDERS B, Devolder E, Jones M, Simren M, et al
    Epidemiology of disorders of gut-brain interaction in Belgium and differences between two language groups: Results from the Rome foundation global epidemiology study.
    Neurogastroenterol Motil. 2023 Apr 5:e14588. doi: 10.1111/nmo.14588.
    PubMed    
    Abstract available
    
    

34. JUNG J, Kim A, Yang SH
    The Innovative Approach in Functional Bladder Disorders: The Communication Between Bladder and Brain-Gut Axis.
    Int Neurourol J. 2023;27:15-22.
    PubMed    
    Abstract available
    
    

35. CALINI G, Abd El Aziz MA, Paolini L, Abdalla S, et al
    Symptomatic Uncomplicated Diverticular Disease (SUDD): Practical Guidance and Challenges for Clinical Management.
    Clin Exp Gastroenterol. 2023;16:29-43.
    PubMed    
    Abstract available
    
    

36. SCHMULSON MJ, Lopez-Colombo A, Montiel Jarquin A, Puentes-Leal GA, et al
    Pictograms to assess bloating and distension symptoms in the general population in Mexico: Results of The Rome Foundation Global Epidemiology Study.
    Neurogastroenterol Motil. 2023 Apr 3:e14577. doi: 10.1111/nmo.14577.
    PubMed    
    Abstract available
    
    

37. FLORES-ARRIAGA J, Aso MC, Izagirre A, Sperber AD, et al
    Prevalence and description of disorders of gut-brain interaction in Spain according to the results of the Rome Foundation Global Epidemiology Study.
    Neurogastroenterol Motil. 2023 Apr 3:e14582. doi: 10.1111/nmo.14582.
    PubMed    
    Abstract available
    
    

38. GHOSHAL UC, Rahman MM, Pratap N, Misra A, et al
    Comparisons of the Rome III and Rome IV criteria for diagnosis of irritable bowel syndrome in Indian and Bangladeshi communities and internal shifts in the diagnostic categories of bowel disorders of gut-brain interactions.
    Neurogastroenterol Motil. 2023 Apr 3:e14579. doi: 10.1111/nmo.14579.
    PubMed    
    Abstract available
    
    

39. HAMAD AJ, Alnaji EK, Almohana SJ, Kareem YS, et al
    ASSOCIATION BETWEEN H. PYLORI INFECTION AND IRRITABLE BOWEL SYNDROME.
    Wiad Lek. 2023;76:406-414.
    PubMed    
    Abstract available
    
    

40. SHIN A, Kashyap PC
    Multi-omics for biomarker approaches in the diagnostic evaluation and management of abdominal pain and irritable bowel syndrome: what lies ahead.
    Gut Microbes. 2023;15:2195792.
    PubMed    
    Abstract available
    
    

41. PETERSEN MW, Carstensen TBW, Frostholm L, Wellnitz KB, et al
    High Perceived Stress and Low Self-Efficacy are Associated with Functional Somatic Disorders: The DanFunD Study.
    Clin Epidemiol. 2023;15:407-419.
    PubMed    
    Abstract available
    
    

42. ZHANG L, Yu C, Chen B, Chao Y, et al
    Corrigendum: Modulation of colonic function in irritable bowel syndrome rats by electroacupuncture at ST25 and the neurobiological links between ST25 and the colon.
    Front Neurosci. 2023;17:1177384.
    PubMed    
    Abstract available
    
    

43. DOMZAL-MAGROWSKA D, Kowalski MK, Malecka-Wojciesko E
    The incidence of adult type hypolactasia in patients with irritable bowel syndrome.
    Prz Gastroenterol. 2023;18:110-114.
    PubMed    
    Abstract available
    
    

44. DUMITRASCU DL, Bakulin I, Berzigotti A, Cravo M, et al
    Update on the Role of Rifaximin in Digestive Diseases.
    J Gastrointestin Liver Dis. 2023;32:92-109.
    PubMed    
    Abstract available
    
    

45. LV MD, Wei YX, Chen JP, Cao MY, et al
    Melatonin attenuated chronic visceral pain by reducing Na(v)1.8 expression and nociceptive neuronal sensitization.
    Mol Pain. 2023 Mar 31:17448069231170072. doi: 10.1177/17448069231170072.
    PubMed    
    Abstract available
    
    

46. CAMILLERI M, Dilmaghani S
    Update on treatment of abdominal pain in irritable bowel syndrome: A narrative review.
    Pharmacol Ther. 2023 Mar 29:108400. doi: 10.1016/j.pharmthera.2023.108400.
    PubMed    
    Abstract available
    
    

47. DAI C, Jiang M, Huang YH
    Efficacy of Mesalamine in Irritable Bowel Syndrome.
    Clin Gastroenterol Hepatol. 2023 Mar 29:S1542-3565(23)00229.
    PubMed    
    
    
    

48. KNOWLES SR, Apputhurai P, Palsson OS, Bangdiwala S, et al
    The epidemioflogy and psychological comorbidity of disorders of gut-brain interaction in Australia: Results from the Rome Foundation Global Epidemiology Study.
    Neurogastroenterol Motil. 2023 Apr 13:e14594. doi: 10.1111/nmo.14594.
    PubMed    
    Abstract available
    
    

49. CUFF C, Lin LD, Mahurkar-Joshi S, Jacobs JP, et al
    Randomized controlled pilot study assessing fructose tolerance during fructose reintroduction in non-constipated irritable bowel syndrome patients successfully treated with a low FODMAP diet.
    Neurogastroenterol Motil. 2023 Apr 13:e14575. doi: 10.1111/nmo.14575.
    PubMed    
    Abstract available
    
    

50. YANG X, Lu S, Feng Y, Cao C, et al
    Characteristics and properties of a polysaccharide isolated from Wolfiporia cocos as potential dietary supplement for IBS.
    Front Nutr. 2023;10:1119583.
    PubMed    
    Abstract available
    
    

51. ALLMAN-FARINELLI M, Boljevac B, Vuong T, Hekler E, et al
    Nutrition-Related N-of-1 Studies Warrant Further Research to Provide Evidence for Dietitians to Practice Personalized (Precision) Medical Nutrition Therapy: A Systematic Review.
    Nutrients. 2023;15:1756.
    PubMed    
    Abstract available
    
    

52. ROSA CD, Altomare A, Terrigno V, Carbone F, et al
    Constipation-Predominant Irritable Bowel Syndrome (IBS-C): Effects of Different Nutritional Patterns on Intestinal Dysbiosis and Symptoms.
    Nutrients. 2023;15:1647.
    PubMed    
    Abstract available
    
    

53. PHAM VT, Steinert RE, Duysburgh C, Ghyselinck J, et al
    In Vitro Effect of Enzymes and Human Milk Oligosaccharides on FODMAP Digestion and Fecal Microbiota Composition.
    Nutrients. 2023;15:1637.
    PubMed    
    Abstract available
    
    

54. SHAIKH SD, Sun N, Canakis A, Park WY, et al
    Irritable Bowel Syndrome and the Gut Microbiome: A Comprehensive Review.
    J Clin Med. 2023;12:2558.
    PubMed    
    Abstract available
    
    

55. HIRAI Y, Horie M
    Nyamanini Virus Nucleoprotein and Phosphoprotein Organize Viral Inclusion Bodies That Associate with Host Biomolecular Condensates in the Nucleus.
    Int J Mol Sci. 2023;24:6550.
    PubMed    
    Abstract available
    
    

56. HUANG YQ, Liu JL, Chen GX, Shen DT, et al
    Berberine Enhances Intestinal Mucosal Barrier Function by Promoting Vitamin D Receptor Activity.
    Chin J Integr Med. 2023 Apr 12. doi: 10.1007/s11655-023-3547.
    PubMed    
    Abstract available
    
    

57. KISS A
    [Thoughts on the "Management of Functional Dyspepsia and Irritable Bowel Syndrome in Practice"].
    Praxis (Bern 1994). 2023;112.
    PubMed    
    
    
    

58. POHL D, Vavricka S, Fox M, Madisch A, et al
    [Frequent Gastro-Intestinal Disorders: Management of Functional Dyspepsia and Irritable Bowel Syndrome in Clinical Practice].
    Praxis (Bern 1994). 2023;112.
    PubMed    
    Abstract available
    
    

59. DE BRUIJN CMA, Geijtenbeek A, Browne PD, Benninga MA, et al
    Children with functional gastrointestinal disorders with and without co-existing nausea: A comparison of clinical and psychological characteristics.
    Neurogastroenterol Motil. 2023 Apr 10:e14591. doi: 10.1111/nmo.14591.
    PubMed    
    Abstract available
    
    

60. KONSTANTIS G, Efstathiou S, Pourzitaki C, Kitsikidou E, et al
    Efficacy and safety of probiotics in the treatment of irritable bowel syndrome: A systematic review and meta-analysis of randomised clinical trials using ROME IV criteria.
    Clin Nutr. 2023;42:800-809.
    PubMed    
    Abstract available
    
    

61. CHEN L, Fan Z, Sun X, Qiu W, et al
    Associations of cholecystectomy with the risk of colorectal cancer: a Mendelian randomization study.
    Chin Med J (Engl). 2023 Mar 30. doi: 10.1097/CM9.0000000000002612.
    PubMed    
    Abstract available
    
    

62. RAJENDRAN V, Ponnusamy A, Pushpavanam S, Jayaraman G, et al
    Continuous protein refolding and purification by two-stage periodic counter-current chromatography.
    J Chromatogr A. 2023;1695:463938.
    PubMed    
    Abstract available
    
    

63. FRIEBE A, Kraehling JR, Russwurm M, Sandner P, et al
    The 10th International Conference on cGMP 2022: recent trends in cGMP research and development-meeting report.
    Naunyn Schmiedebergs Arch Pharmacol. 2023.
    PubMed    
    Abstract available
    
    

64. FUNAYAMA T, Nozu T, Ishioh M, Igarashi S, et al
    Centrally administered GLP-1 analogue improves intestinal barrier function through the brain orexin and the vagal pathway in rats.
    Brain Res. 2023 Apr 17:148371. doi: 10.1016/j.brainres.2023.148371.
    PubMed    
    Abstract available
    
    

65. WANG L, Xiao S, Zheng Y, Gao Z, et al
    CircRNA circSLIT2 is a novel diagnostic and prognostic biomarker for gastric cancer.
    Wien Klin Wochenschr. 2023 Apr 19. doi: 10.1007/s00508-023-02155.
    PubMed    
    Abstract available
    
    

66. ZHENG H, Zhang C, Zhang J, Duan L, et al
    "Sentinel or accomplice" - gut microbiota and microglia cross-talk in disorders of gut-brain interaction.
    Protein Cell. 2023 Apr 19:pwad020. doi: 10.1093.
    PubMed    
    Abstract available
    
    

67. LIU M, Xu J, Jin Q, Li Y, et al
    Interaction of Intestinal Microbiota with Medications.
    Curr Drug Metab. 2023 Apr 18. doi: 10.2174/1389200224666230418104540.
    PubMed    
    Abstract available
    
    

68. JUNG EH, Zheng W, Weiss RJ, Mathew NE, et al
    Colopathy Associated with Pentosan Polysulfate Use.
    medRxiv. 2023 Apr 4:2023.04.03.23288071. doi: 10.1101/2023.04.03.23288071.
    PubMed    
    Abstract available
    
    

69. ABENAVOLI L
    Editorial: Global excellence in gastroenterology: Europe.
    Front Med (Lausanne). 2023;10:1188047.
    PubMed    
    
    
    

70. CHOI NR, Kwon MJ, Choi WG, Kim SC, et al
    The traditional herbal medicines mixture, Banhasasim-tang, relieves the symptoms of irritable bowel syndrome via modulation of TRPA1, NaV1.5 and NaV1.7 channels.
    J Ethnopharmacol. 2023 Apr 12:116499. doi: 10.1016/j.jep.2023.116499.
    PubMed    
    Abstract available
    
    

71. SAVIN E, Tsur AM, Watad A, Gendelman O, et al
    Association of fibromyalgia with cancerous and non-cancerous gastrointestinal comorbidities: a cross-sectional study.
    Clin Exp Rheumatol. 2023 Apr 3. doi: 10.55563.
    PubMed    
    Abstract available
    
    

72. ZHAO H, Zhang C, Tao R, Duan H, et al
    Distinct inter-brain synchronization patterns underlying group decision-making under uncertainty with partners in different interpersonal relationships.
    Neuroimage. 2023;272:120043.
    PubMed    
    Abstract available
    
    

73. MARASCO G, Maida M, Cremon C, Barbaro MR, et al
    Meta-analysis: Post-COVID-19 functional dyspepsia and irritable bowel syndrome.
    Aliment Pharmacol Ther. 2023 Apr 10. doi: 10.1111/apt.17513.
    PubMed    
    Abstract available
    
    

74. GRAD R, Ebell MH
    Top 20 Research Studies of 2022 for Primary Care Physicians.
    Am Fam Physician. 2023;107:406-414.
    PubMed    
    Abstract available
    
    

75. BALLOU S, Rangan V, Eidelberg A, Proctor S, et al
    What is unspecified functional bowel disorder? A commonly seen, rarely recognized, and poorly understood diagnosis.
    Am J Gastroenterol. 2023 Apr 13. doi: 10.14309/ajg.0000000000002281.
    PubMed    
    Abstract available
    
    

76. YANG PL, Kamp KJ, Burr RL, Tang HJ, et al
    Age Differences in Core Symptoms and Symptom Relationships in Patients with Irritable Bowel Syndrome: A Network Analysis.
    Am J Gastroenterol. 2023 Apr 11. doi: 10.14309/ajg.0000000000002280.
    PubMed    
    Abstract available
    
    

77. KALOLA UK, Chowdhury YS, Wang J, Tao L, et al
    The role of sex hormones in the fecal microbiota of IBS-D patients with exacerbation of symptoms deserves attention.
    J Gastroenterol. 2023;58:425-426.
    PubMed    
    Abstract available
    
    

78. SCHORLING E, Lick S, Steinberg P, Bruggemann DA, et al
    Health care utilizations and costs of Campylobacter enteritis in Germany: A claims data analysis.
    PLoS One. 2023;18:e0283865.
    PubMed    
    Abstract available